Abstract
Lumbar degenerative disc disease (LDDD) is frequently misdiagnosed as other spine conditions, and the accurate diagnosis is challenging. This study was conducted to explore the role of circRNA GRB10 in the accurate diagnosis of LDDD. This study included 60 cases of LDDD, 60 cases of patients with sacroiliac joint pain (SJP), 60 cases of lumbar disc herniation (LDH), 60 cases of piriformis syndrome (PS), 60 cases of entrapment neuropathy (EN) and 60 cases of healthy controls (HCs). Plasma was obtained from each patient before and after treatment. Expression of GRB10 was studied with RT-qPCR. The role of plasma GRB10 in the accurate diagnosis of LDDD was analyzed by ROC curve analysis. Compared to HCs, decreased accumulation of GRB10 RNA was only observed in LDDD group, but not in SJP, LDH, PS and EN groups. With plasma expression level of GRB10 measured before treatment as a biomarker, LDDD patients were separated from SJP, LDH, PS, EN and HC groups. After treatment, increased expression levels of GRB10 were only observed in LDDD group, but not in other groups. Therefore, GRB10 was downregulated in LDDD and may serve as a biomarker for the accurate diagnosis of LDDD.
Similar content being viewed by others
Data Availability
The data were available from corresponding author upon reasonable request.
References
Taher, F., Essig, D., Lebl, D. R., Hughes, A. P., Sama, A. A., Cammisa, F. P., & Girardi, F. P. (2012). Lumbar degenerative disc disease: Current and future concepts of diagnosis and management. Advances in Orthopedics, 2012, 970752.
Formica, C., Zanirato, A., Divano, S., Basso, M., Cavagnaro, L., Alessio Mazzola, M., Vellone, V. G., Mastrogiacomo, M., Berjano, P., Felli, L., & Formica, M. (2020). Total disc replacement for lumbar degenerative disc disease: Single centre 20 years experience. European spine journal : Official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 29, 1518–1526.
Ravindra, V. M., Senglaub, S. S., Rattani, A., Dewan, M. C., Härtl, R., Bisson, E., Park, K. B., & Shrime, M. G. (2018). Degenerative lumbar spine disease: Estimating global incidence and worldwide volume. Global Spine Journal, 8, 784–794.
Parenteau, C. S., Lau, E. C., Campbell, I. C., & Courtney, A. (2021). Prevalence of spine degeneration diagnosis by type, age, gender, and obesity using Medicare data. Scientific Reports, 11, 5389.
MacLean, M. A., Touchette, C. J., Han, J. H., Christie, S. D., & Pickett, G. E. (2020). Gender differences in the surgical management of lumbar degenerative disease: a scoping review. Journal of Neurosurgery: Spine. https://doi.org/10.3171/2019.11.SPINE19896
Park, C. K. (2015). Total disc replacement in lumbar degenerative disc diseases. Journal of Korean Neurosurgical Society, 58, 401–411.
Yolcu, Y. U., Moinuddin, F. M., Wahood, W., Alvi, M. A., Qu, W., & Bydon, M. (2020). Use of regenerative treatments in treatment of lumbar degenerative disc disease: A systematic review. Clinical Neurology and Neurosurgery, 195, 105916.
Kalakoti, P., Sciubba, D. M., Pugely, A. J., McGirt, M. J., Sharma, K., Patra, D. P., Phan, K., Madhavan, K., Menger, R. P., Notarianni, C., Guthikonda, B., Nanda, A., & Sun, H. (2018). Impact of psychiatric comorbidities on short-term outcomes following intervention for lumbar degenerative disc disease. Spine, 43, 1363–1371.
Ajiboye, L. O., Alimi, M., Gbadegesin, S. A., & Oboirien, M. (2019). Treatment outcome of quality of life and clinical symptoms in patients with symptomatic lumbar degenerative disc diseases: Which treatment modality is superior? International Orthopaedics, 43, 875–881.
Behbahani, M., Shlobin, N., Rosen, C., Yerkes, E., Swaroop, V., Lam, S., & Bowman, R. (2020). Multidisciplinary management of tethered spinal cord syndrome in children: Operationalizing an outpatient patient-centered workflow. Journal of Multidisciplinary Healthcare, 13, 1283–1290.
Sharma, P., Ranjan, A., & Lath, R. (2014). Arteriovenous fistula of the filum terminale misdiagnosed and previously operated as lower lumbar degenerative disease. Asian Spine Journal, 8, 365–370.
Divi, S. N., Markova, D. Z., Fang, T., Guzek, R., Kurd, M. F., Rihn, J. A., Hilibrand, A. S., Anderson, D. G., Vaccaro, A. R., Schroeder, G. D., & Kepler, C. K. (2020). Circulating miR-155-5p as a novel biomarker of lumbar degenerative disc disease. Spine, 45, E499-e507.
Park, J.-S., Moon, S. W., & Han, H. (2021). Biomarker for degenerative disc diseases: Clusterin. Osteoarthritis and Cartilage, 29, S127–S128.
Verduci, L., Tarcitano, E., Strano, S., Yarden, Y., & Blandino, G. (2021). CircRNAs: Role in human diseases and potential use as biomarkers. Cell Death & Disease, 12, 468.
Zhu, J., Zhang, X., Gao, W., Hu, H., Wang, X., & Hao, D. (2019). lncRNA/circRNA-miRNA-mRNA ceRNA network in lumbar intervertebral disc degeneration. Molecular Medicine Reports, 20, 3160–3174.
Guo, W., Zhang, B., Mu, K., Feng, S. Q., Dong, Z. Y., Ning, G. Z., Li, H. R., Liu, S., Zhao, L., Li, Y., Yu, B. B., Duan, H. Q., Sun, C., & Li, Y. J. (2018). Circular RNA GRB10 as a competitive endogenous RNA regulating nucleus pulposus cells death in degenerative intervertebral disk. Cell Death & Disease, 9, 319.
Guo, W., Mu, K., Zhang, B., Sun, C., Zhao, L., Li, H. R., Dong, Z. Y., & Cui, Q. (2020). The circular RNA circ-GRB10 participates in the molecular circuitry inhibiting human intervertebral disc degeneration. Cell Death & Disease, 11, 612.
Acknowledgements
Not applicable.
Funding
This work is supported by Science and Technology Innovation Action Plan of Shanghai Medical Innovation Research Project (Grant Number 20Y11913000); Sailing Plan of Shanghai Science and Technology Committee (Grant Number 21YF1439000).
Author information
Authors and Affiliations
Contributions
Conception and design: YJ. Administrative support: All authors. Provision of study materials or patients: All authors. Collection and assembly of data: All authors. Data analysis and interpretation: All authors. Manuscript writing: LW, JG. Final approval of manuscript: All authors.
Corresponding author
Ethics declarations
Conflict of interest
The author reports no conflict of interest in this work.
Ethics Approval and Informed Consent
The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. For human experiments, the trial was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the human Ethics Committee of the Shanghai Guanghua Hospital of Integrative Medicine and informed consent was taken from all individual participants.
Consent for Publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wei, L., Guo, J., Zhai, W. et al. CircRNA GRB10 is a Novel Biomarker for the Accurate Diagnosis of Lumbar Degenerative Disc Disease. Mol Biotechnol 65, 816–821 (2023). https://doi.org/10.1007/s12033-022-00574-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-022-00574-1